Detalhe da pesquisa
1.
Efficacy and safety profile of long-term exposure to lenalidomide in patients with recurrent multiple myeloma.
Cancer
; 119(20): 3680-6, 2013 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23921945
2.
Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO.
Leukemia
; 37(1): 91-101, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376378
3.
Prognostic value of PINI index in patients with multiple myeloma.
Eur J Haematol
; 88(4): 306-13, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22126676
4.
Bendamustine is effective in T-cell prolymphocytic leukaemia.
Br J Haematol
; 168(6): 916-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25316212
5.
Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohort.
Int J Antimicrob Agents
; 53(6): 781-788, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30831232
6.
Mixed phenotype acute leukaemia with Burkitt-like cells and positive peroxidase cytochemistry.
Br J Haematol
; 163(2): 148, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23930593
7.
IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia.
Clin Cancer Res
; 22(20): 5152-5158, 2016 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27169996
8.
IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association.
Oncotarget
; 6(39): 42345-53, 2015 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26486081
9.
[Brentuximab vedotin: new treatment for CD30+ lymphomas]. / Brentuximab vedotin: nouvelle option thérapeutique dans la prise en charge des lymphomes CD30+
Bull Cancer
; 100(7-8): 775-9, 2013.
Artigo
em Francês
| MEDLINE | ID: mdl-23831822